Mutant E-cadherin breast cancer cells do not display constitutive Wnt signaling

Cancer Research

Volumn 61, Issue 1, 2001, Pages 278-284

  Van De Wetering, Marc ^a   Barker, Nick ^a   Harkes, I Clara ^c   Van Der Heyden, Marcel ^d   Dijk, Nicolette J ^c   Hollesteue, Antoinette ^c   Klijn, Jan G M ^c   Clevers, Hans ^a,b   Schutte, Mieke ^c  

^a Department of Immunology ^*  (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

^d HUBRECHT INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; MUTANT PROTEIN; T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; UVOMORULIN; WNT PROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; GENE DELETION; GENE MUTATION; GENE SEQUENCE; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REPORTER GENE; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; CADHERINS; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; GENE EXPRESSION; GENE SILENCING; GENES, REPORTER; HUMANS; LUCIFERASES; LYMPHOID ENHANCER-BINDING FACTOR 1; MUTATION; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; WNT PROTEINS; ZEBRAFISH PROTEINS;

EID: 0035138178     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (79)

1. Wnt signalling: Pathway or network?
2. TCF transcription factors: Molecular switches in carcinogenesis
3. Wnt signaling in oncogenesis and embryogenesis: A look outside the nucleus
4. The Yin-Yang of TCF/β-catenin signaling
5. Association of the APC gene product with β-catenin
6. Association of the APC tumor suppressor protein with catenins
7. Binding of GSK3β to the APC-β-catenin complex and regulation of complex assembly
8. The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation
9. Functional interaction of an axin homolog, conductin, with β-catenin, APC, and GSK3β
10. Bridging of β-catenin and glycogen synthase kinase-3β by axin and inhibition of β-catenin-mediated transcription
11. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3β and β-catenin and promotes GSK-3β-dependent phosphorylation of β-catenin
12. Down-regulation of β-catenin by human Axin and its association with the APC tumor suppressor, β-catenin and GSK3 β
13. Axil, a member of the Axin family, interacts with both glycogen synthase kinase 3β and β-catenin and inhibits axis formation of Xenopus embryos
14. β-catenin is a target for the ubiquitin-proteasome pathway
15. The SCFβ-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IκBα and β-catenin and stimulates IκBα ubiquitination in vitro
16. β-Trcp couples β-catenin phosphorylation-degradation and regulates Xenopus axis formation
17. The F-box protein β-TrCP associates with phosphorylated β-catenin and regulates its activity in the cell
18. The human F box protein β-Trcp associates with the Cull/Skp1 complex and regulates the stability of β-catenin
19. XTcf-3 transcription factor mediates β-catenin-induced axis formation in Xenopus embryos
20. Functional interaction of β-catenin with the transcription factor LEF-1
21. Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF
22. Identification of c-MYC as a target of the APC pathway
23. β-catenin regulates expression of cyclin D1 in colon carcinoma cells
24. Synergy between tumor suppressor APC and the β-catenin-Tcf4 target Tcf1
25. Lessons from hereditary colorectal cancer
26. The adenomatous polyposis coli (APC) tumor suppressor
27. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/-colon carcinoma
28. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC
29. Stabilization of β-catenin by genetic defects in melanoma cell lines
30. β-catenin signaling and cancer
31. Wnt signaling and cancer
32. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
33. Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating β-catenin/TCF signalling
34. Cadherins and tissue formation: Integrating adhesion and signaling
35. Regulation of cadherin adhesive activity
36. The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species
37. Proteins associated with the cytoplasmic surface of adhesion molecules
38. Unraveling the cytoplasmic interactions of the cadherin superfamily
39. Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/β-catenin complex in cells transformed with a temperature-sensitive v-SRC gene
40. Tyrosine phosphorylation regulates the adhesions of ras-transformed breast epithelia
41. β-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor
42. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene
43. A causal role for E-cadherin in the transition from adenoma to carcinoma
44. E-Cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells
45. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model
46. E-cadherin transfection down-regulates the epidermal growth factor receptor and reverses the invasive phenotype of human papilloma virus-transfected keratinocytes
47. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role
48. Role of morphogenetic factors in metastasis of mammary carcinoma cells
49. Suppression of prostate cancer invasive potential and matrix metalloproteinase activity by E-cadherin transfection
50. The E-cadherin/catenin complex in invasion and metastasis
51. Mutations of the human E-cadherin (CDH1) gene
52. Identification of eleven novel tumor-associated E-cadherin mutations. Mutations in brief no. 215
53. E-cadherin binding prevents β-catenin nuclear localization and β-catenin/LEF-1-mediated transactivation
54. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers
55. Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region
56. Cultivation of human breast carcinomas
57. Morphological and biochemical properties of a new human breast cancer cell line
58. A human cell line from a pleural effusion derived from a breast carcinoma
59. Breast tumor cell lines from pleural effusions
60. Human breast carcinoma cells in continuous culture: A review
61. A human breast adenocarcinoma with chromosome and isoenzyme markers similar to those of the HeLa line
62. Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells
63. 1.25-dihydroxyvitamin D3 specifically binds to a human breast cancer cell line (T47D) and stimulates growth
64. Establishment of two new cell lines derived from human breast carcinomas with HER-2/neu amplification
65. Establishment and characterization of three new continuous cell lines derived from human breast carcinomas
66. Two syngeneic cell lines from human breast tissue: The aneuploid mammary epithelial (Hs578T) and the diploid myoepithelial (Hs578Bst) cell lines
67. Immortalization in culture: Occurrence at a late stage in the progression of breast cancer
68. Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media
69. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas
70. Mechanisms of inactivation of E-cadherin in breast cancer cell lines
71. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain
72. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome
73. Mode of proviral activation of a putative mammary oncogene (inyt-1) on mouse chromosome 15
74. Restricted high level expression of Tcf-4 protein in intestinal and mammary gland epithelium
75. APC truncation and increased β-catenin levels in a human breast cancer cell line
76. Aberrations of the APC gene in primary breast carcinoma
77. β-and γ-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer
78. Methylation patterns of the E-cadherin 5′ CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression
79. Uncoupling cadherin-based adhesion from wingless signalling in Drosophila